Followers | 7 |
Posts | 5499 |
Boards Moderated | 0 |
Alias Born | 09/11/2013 |
Friday, July 24, 2020 11:18:40 AM
https://www.sec.gov/Archives/edgar/data/1379006/000114036107006096/ex10_12.htm
EX-10.12 3 ex10_12.htm EXHIBIT 10.12
Dec 23, 2005
To
Nguyen Tran Hien, MD, MPH, PhD
Director
National Institute of Hygiene and Epidemiology (NIHE)
1 Yersin Street
Hanoi, Viet Nam
Dear Dr. Hien:
Enclosed please find a Memorandum of understanding between NanoViricides, Incorporated, USA, and NIHE, Viet Nam, as per our discussions for the purposes of cooperation between NanoViricides, Inc., and NIHE for novel nanotechnology-based prevention strategies, therapies and diagnostics strategies for Influenza A subtype H5N1,
We look forward to a fruitful cooperation in many areas.
Sincerely,
/s/Anil R. Diwan
Anil R. Diwan, Ph.D.
President & Chairman
NanoViricides, Inc.
Mobile: 203-606-9180
email: adiwan@nanoviricides.com
or adiwan@snet.net
cc:
Dang Duc Anh, PhD
Vice Director, NIHE.
135 Wood Street, Ste. 205, West Haven, CT 06516, USA.
Memorandum of Understanding
Between
NIHE, Viet Nam and NanoViricides, Inc., USA
NANOVIRICIDES, INC. 135 Wood Street, Suite 205, West Haven, CT 06516, and National Institute of Hygiene and Epidemiology (NIHE), 1 Yersin Street, Hanoi, Viet Nam, agree to enter into a scientific research cooperation on the development of prevention, diagnostics, and therapeutic strategies for Influenza A subtype H5N1, including:
*
Research on Novel Nanotechnology-based Vaccines (NanoVaccines),
*
Research on Novel Nanotehnology-based Therapies (NanoViricides), and
*
Research on Novel Nanotechnology-based Diagnostics,
It Is understood that these development projects will begin as small projects. As success Is achieved, the projects can be continued for further development.
These various strategies are based on the nanotechnology intellectual property and products of NanoViricides, Inc.
NanoViricides, Inc. shall retain all intellectual property rights to resulting products and technologies and shall make full efforts for world-wide protection of such intellectual property rights.
Certain rights for the new nanotechnology products and technologies develop shall be provided to NIHE for use in Viet Nam.
The work plan, costs budget, compensation and financial responsibilities of each party to the projects shall be determined in the final Agreement.
It Is understood that both parties will be sharing confidential information and intellectual property of the other party, and will ensure that such information is protected to its fullest and not publicly disclosed except by written consent from the other party when so decided.
Signed: December 23, 2005 by both parties at NIHE, Hanoi, Viet Nam
/s/ Nguyen Tran Hien
/s/ Anil R. Diwan
Professor Nguyen Tran Hien, MD, MPH, PhD
Anil R. Diwan, Ph.D.
Director
President & Chairman
National Institute of Hygiene and Epidemiology
Nanoviricides, Inc.
1 Yersin Street
135 Wood Street, Ste. 205
Hanoi, Viet Nam
West Haven, CT 06516, USA.
Page 1 of 1
Just because you can doesn't mean you should.
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM